🇺🇸 FDA
Patent

US 11304911

Compositions and methods for organ specific delivery of nucleic acids

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 11304911 (Compositions and methods for organ specific delivery of nucleic acids) held by The Board of Regents of the University of Texas System expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/7105, A61K31/713, A61K47/6907, A61K47/6929